Columbia Business School

Vittoria Biotherapeutics Announces Keith Westby as Chief Operating Officer

Retrieved on: 
화요일, 4월 16, 2024
Physics, Applied physics, State university system, OSI Pharmaceuticals, CD5, T-cell lymphoma, Therapy, Patient, Acquisition, Drexel University, Columbia Business School, MBA, Biotechnology, Retina, Organization, Pharmaceutical industry

PHILADELPHIA, April 16, 2024 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, a clinical-stage cell therapy company, has announced that Keith Westby has joined the company as its inaugural Chief Operating Officer.

Key Points: 
  • PHILADELPHIA, April 16, 2024 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics, a clinical-stage cell therapy company, has announced that Keith Westby has joined the company as its inaugural Chief Operating Officer.
  • Mr. Westby brings over two decades of biotechnology entrepreneurial experience and a proven track record of building successful organizations.
  • In his role, Mr. Westby will manage the advancement of Vittoria’s novel therapeutics into the clinic, including Vittoria’s lead program, VIPER-101, for the treatment of T-cell lymphoma.
  • Mr. Westby oversaw company operations and strategy and was instrumental in the $6 billion acquisition of Iveric Bio by Astellas.

Powerfleet Appoints Andrew Martin to Board of Directors

Retrieved on: 
화요일, 4월 30, 2024
Credit Suisse, Credit Suisse First Boston, Research, Business, Growth, Cornell University, Bachelor of Science, PCM, H.I.G. Capital, Columbia Business School, MBA, Economics, Partner, Management

WOODCLIFF LAKE, N.J., April 30, 2024 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: PWFL) today announced that Andrew Martin of Private Capital Management, LLC ("PCM"), one of the company's largest shareholders, has joined its board of directors as an independent member of the board.

Key Points: 
  • WOODCLIFF LAKE, N.J., April 30, 2024 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: PWFL) today announced that Andrew Martin of Private Capital Management, LLC ("PCM"), one of the company's largest shareholders, has joined its board of directors as an independent member of the board.
  • "We are excited to welcome Andrew Martin to the Powerfleet board," said Steve Towe, Chief Executive Officer at Powerfleet.
  • "I am delighted for Andrew to join our new board of directors," added Michael Brodsky, Chairman of Powerfleet's board.
  • "As a large shareholder with a long-term position in the company, it is highly energizing to be joining the Powerfleet board of directors," said Mr. Martin.

Resilient Waters Fund Wins the 2024 Kellogg-Morgan Stanley Sustainable Investing Challenge

Retrieved on: 
월요일, 4월 22, 2024
Sustainability, Environment, Finance, Environmental, Social and Governance (ESG), Banking, Professional Services, University, Education, Great Salt Lake, Seed, Risk, Morgan Stanley, Kellogg School of Management, Socially responsible investing, Human back, Water, Business, Farmer, Northwestern University, Columbia Business School, Creativity, Student, Renewable energy

The Morgan Stanley Institute for Sustainable Investing and Kellogg School of Management at Northwestern University today announced that the Resilient Waters Fund team was named the winner of the 14th annual Kellogg-Morgan Stanley Sustainable Investing Challenge.

Key Points: 
  • The Morgan Stanley Institute for Sustainable Investing and Kellogg School of Management at Northwestern University today announced that the Resilient Waters Fund team was named the winner of the 14th annual Kellogg-Morgan Stanley Sustainable Investing Challenge.
  • The winning team was one of 12 finalists selected from a competitive field, which included 84 teams comprised of 290 students from 44 countries.
  • The Resilient Waters Fund would catalyze federal, state and investment funds through a creative land trust mechanism to spur irrigation efficiency, responsible cropping and water savings.
  • “Through the Sustainable Investing Challenge, students develop financial solutions to real-world issues, providing them with invaluable experience and insights into sustainable finance,” says Jessica Alsford, Morgan Stanley’s Chief Sustainability Officer and CEO of the Institute for Sustainable Investing.

Black & Veatch Names Chief People Officer Andrea Bernica to Company’s Board of Directors

Retrieved on: 
수요일, 4월 17, 2024
Urban Planning, Manufacturing, Construction & Property, Professional Services, Building Systems, Other Energy, Utilities, Energy, Engineering, Human Resources, Other Construction & Property, Columbia Business School, Culture, Black & Veatch, University, Growth, Colorado State University, Management

Andrea Bernica, Black & Veatch’s chief people officer, has been named to the board of directors of the global leader in sustainable infrastructure solutions, the entirely employee-owned company announced today.

Key Points: 
  • Andrea Bernica, Black & Veatch’s chief people officer, has been named to the board of directors of the global leader in sustainable infrastructure solutions, the entirely employee-owned company announced today.
  • “Andrea exemplifies the qualities of a strong and effective leader and is a role model and mentor to our many talented women professionals and leaders,” Black & Veatch Chairman and CEO Mario Azar said.
  • In her 13 years with Black & Veatch, Bernica has served as chief of staff, lead employment and corporate counsel, as well as operated as the Board of Directors secretary designee.
  • Bernica received her juris doctor degree from the University of Notre Dame, and a bachelor’s degree from Colorado State University.

Obsidian Therapeutics Appoints Jeffrey Trigilio as Chief Financial Officer

Retrieved on: 
월요일, 4월 15, 2024
Biotechnology, Health, Genetics, Pharmaceutical, Oncology, Credit Suisse, Corporate finance, RBC Capital Markets, Amylyx Pharmaceuticals, Alexion Pharmaceuticals, Cornell University, TIL, Record, Columbia Business School, Therapy, Growth

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of Jeffrey Trigilio as Chief Financial Officer, effective May 1, 2024.

Key Points: 
  • Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of Jeffrey Trigilio as Chief Financial Officer, effective May 1, 2024.
  • “We are thrilled to welcome Jeff to the Obsidian leadership team as the company’s Chief Financial Officer,” said Madan Jagasia, M.D., Chief Executive Officer of Obsidian.
  • Most recently, he served as Chief Financial Officer of Cullinan Oncology, where he guided its initial public offering and helped secure several business development transactions for its portfolio.
  • Before Cullinan, Mr. Trigilio served as Chief Financial Officer for Amylyx Pharmaceuticals, Vice President of Corporate Finance at BlueRock Therapeutics, and in various corporate strategy and finance roles at Alexion Pharmaceuticals.

Glenmede Appoints Brian Green as New Chief Investment Officer of Private Wealth

Retrieved on: 
수요일, 4월 10, 2024
Consulting, Asset Management, Professional Services, Finance, BNY Mellon, University, JPMorgan Chase, Investment strategy, Policy, Private, Investment management, CFA Institute, Research, Business administration, London Business School, Wealth, Committee, Columbia Business School, Multimedia, CIO, Accounting, Associate, Government, Philosophy, Management

Glenmede, a privately held and independently owned investment and wealth management firm, today announced the appointment of Brian K. Green, CFA®, as Chief Investment Officer (CIO) of Private Wealth, reporting to Thomas P. Melcher, Director of Private Wealth.

Key Points: 
  • Glenmede, a privately held and independently owned investment and wealth management firm, today announced the appointment of Brian K. Green, CFA®, as Chief Investment Officer (CIO) of Private Wealth, reporting to Thomas P. Melcher, Director of Private Wealth.
  • View the full release here: https://www.businesswire.com/news/home/20240410583764/en/
    Mr. Green will co-chair the Private Wealth Investment Policy Committee and oversee the Portfolio Construction Consulting Group, a specialized group of professionals who support portfolio managers in their management of complex relationships.
  • “Glenmede Private Wealth’s mission is to empower the confident pursuit of purpose, passions and legacy through integrated wealth management.
  • Previously, Mr. Green was Glenmede’s Director of Private Wealth Portfolio Management and Associate Director of Investment Management.

Newman's Own, Inc. Appoints Anne Laraway to its Board of Directors

Retrieved on: 
수요일, 4월 24, 2024
University, Happy Family (food company), Food, Unilever, Columbia Business School, MBA, General Mills, CPG, Management

"We are delighted to have Anne join the Newman's Own, Inc. Board of Directors," said Ellen Marram, board chair.

Key Points: 
  • "We are delighted to have Anne join the Newman's Own, Inc. Board of Directors," said Ellen Marram, board chair.
  • I look forward to continuing to further the mission that Paul Newman originally set for the company," said Ms. Laraway.
  • Ms. Laraway serves on the Board of Directors for BabyNov USA.
  • In the past, she served as the Board Chair for Metropolitan Lighthouse (now Nuasin Next Generation) Charter School in the Bronx.

SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer

Retrieved on: 
월요일, 4월 22, 2024
D'Elía, University, Cancer, Hematology, Virology, Baxter International, Business, Growth, AstraZeneca, Simcere Pharmaceutical, Therapy, Senior, Patient, Bristol Myers Squibb, Fibrosis, College, Columbia Business School, MBA, BMS, Boston Consulting Group, Jie, Drug development, Spacecraft, Moses Austin, Strategic planning, Fine chemical

Dr. D'Elia's extensive experience in drug development, strategic planning, and business development is poised to propel SystImmune into its next phase of growth and innovation.

Key Points: 
  • Dr. D'Elia's extensive experience in drug development, strategic planning, and business development is poised to propel SystImmune into its next phase of growth and innovation.
  • I look forward to working with her as we steer SystImmune towards new horizons of development and success."
  • Its highly differentiated platforms discovering bi-specific and multi-specific antibodies and ADCs stand out as a testament to its innovative capabilities.
  • Dr. D'Elia received her Ph.D. from the College of Pharmacy at the University of Texas at Austin and her MBA from Columbia Business School.

Horatio Honored As Dual Winners STEVIE® AWARD WINNER In 2024 Stevie® Awards For Sales & Customer Service

Retrieved on: 
화요일, 4월 16, 2024
Silver, City centre, Safety, Stevie Awards, Entrepreneurship, Customer service, Customer, Trust, Columbia Business School, Organization, Growth

NEW YORK, April 16, 2024 /PRNewswire/ -- Horatio, the customer service outsourcing company disrupting the industry at large, has been named one of 2024's STEVIE® award winners in the 18th annual Stevie® Awards for Sales & Customer Service.  Horatio received a bronze award in the category of Contact Center or Customer Service Outsourcing Provider of the Year. Horatio CEO and Co-Founder, Jose Herrera, was awarded the silver medal for the 2024 Customer Service Leader of the Year.

Key Points: 
  • NEW YORK, April 16, 2024 /PRNewswire/ -- Horatio , the customer service outsourcing company disrupting the industry at large, has been named one of 2024's STEVIE® award winners in the 18th annual Stevie® Awards for Sales & Customer Service.
  • Horatio received a bronze award in the category of Contact Center or Customer Service Outsourcing Provider of the Year.
  • Horatio CEO and Co-Founder, Jose Herrera , was awarded the silver medal for the 2024 Customer Service Leader of the Year.
  • The Stevie Awards for Sales & Customer Service recognize the achievements of premiere sales, customer service, and call center professionals worldwide.

Noventiq Appoints Jerry Letter as Chief Financial Officer and Head of Corporate Development

Retrieved on: 
수요일, 4월 3, 2024
Technology, Finance, Security, Banking, Professional Services, Software, Networks, Internet, Hardware, Artificial Intelligence, Certified Public Accountant, Growth, InterMedia Partners, CFO, Letter, Business, Accounting, Columbia Business School, Acquisition, Airbnb, MBA, New York Yankees, Silicon, YES Network, Partner, Multimedia, ABNB, Arthur Andersen, Corporate development, Intermedia, Management

Noventiq Holdings PLC (“Noventiq” or “the Company”), a global digital transformation and cybersecurity solutions and services provider, today announced the appointment of Jerry Letter as Chief Financial Officer and Head of Corporate Development.

Key Points: 
  • Noventiq Holdings PLC (“Noventiq” or “the Company”), a global digital transformation and cybersecurity solutions and services provider, today announced the appointment of Jerry Letter as Chief Financial Officer and Head of Corporate Development.
  • View the full release here: https://www.businesswire.com/news/home/20240402610033/en/
    Jerry Letter, Chief Financial Officer and Head of Corporate Development, Noventiq (Photo: Business Wire)
    Mr. Letter brings over 25 years of experience across U.S. public markets, corporate finance, and global operations and finance in senior leadership roles, including expertise in capital markets and M&A transactions.
  • Most recently, as Chief Financial Officer and Chief Operating Officer of Corner Growth Acquisition Corp. (Nasdaq: COOL), he has worked closely with Noventiq ahead of its proposed business combination and Nasdaq listing.
  • Mr. Letter also served as Chief Financial Officer and Chief Operating Officer of Corner Growth Acquisition Corp.